As the technological environment is swiftly undergoing evolution, companies operating in the healthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector’s growth is boosted by the rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings. To address the rising demand for better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved therapies especially in the field of cancer treatment wherein the radiation therapy is gaining quick acceptance.
Radiation therapy (RT) deploys ionized radiation and limits the proliferation of malignant cells by impairing their DNA. Radiation therapy involves the application of various types of radiations including photons, electron beams, proton beams and neutron beams. Also, the treatment regimes are classified as external radiation therapy, internal radiation therapy or brachytherapy and systemic radioisotope therapy.
This report elicits the global radiation therapy market with focus on key regional markets like North America, EMEA, Asia Pacific and Latin America. Also, industry developments like development of LINACs, rapid Arc therapy and proton therapy; growth drivers including rising cancer cases, increasing use of alcohol and tobacco, expanding obese population and ageing population, rising healthcare expenditure and increasing GNI; and challenges like fatal cancer types, risks associated with treatment procedure and side effects, increasing treatment costs and price pressure among others are discussed in detail. Furthermore, the competitive scenario of the global radiation therapy market, along with the profiles of top 4 industry players viz. Varian, Elekta, Siemens, and Accuray are being included in the report.
The Term Paper on Breast Cancer Radiation Treatment Chemotherapy
Introduction, Signs and Symptoms, Terminology, Definitions ONE Patients diagnosed with breast cancer should obtain a second opinion as soon as possible. Chapter 2 ONE Breast cancer begins with a single glandular mutation in the breast. ONE Risks Previous breast cancer, age over 50 and strong history of family breast cancer increases a patients risk for breast cancer. ONE Risks Minor risk factors ...
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.
